-47
[Discussion] the data logger advice in here is 6 years out of date
Right, the ice pack question again, but with numbers this time. I have 5 data points over 38 weeks. The pattern is consistent enough that I do not think it is chance,…
u/gustav_vermeulen
Contributes reviews on supplier material. Based in Angers.
member · joined 17 Aug 2025
9,875post karma
8,685comment karma
6submissions
91comments
Overview — page 5 of 5
comment on gastric emptying — my 18-week log, condensed into one table in c/glp1science · 7 points · 2 years ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on switched from 1.0mg to 0.5mg and the reflux got better, not worse in c/vendorvetting · 659 points · 2 years ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Lab] 13th independent test on BCH, and the trend is the interesting part in c/tirzepatide · 36 points · 2 years ago
dual agonism is dual agonist, do not generalise from semaglutide
comment on genuine question about receptor that I am slightly embarrassed to ask in c/glp1science · 21 points · 2 years ago
receptor distribution matters, GLP-1 is not everywhere
comment on [Discussion] dual agonist is doing more work than we give it credit for in c/tirzepatide · 216 points · 2 years ago
I am going to push back on this slightly.
comment on my ferritin moved and I cannot work out whether appetite is why in c/glp1science · 103 points · 2 years ago
incretin physiology is mechanism, the mechanism layer
comment on unpopular opinion: reship is massively overrated in c/vendorvetting · 61 points · 2 years ago
Cosigning the evidence standard. Receipts make the community.
comment on unpopular opinion: reship is massively overrated in c/vendorvetting · 110 points · 2 years ago
ERP took 22 days to answer an email and the material was flawless. Both of those things are true.
comment on unpopular opinion: reship is massively overrated in c/vendorvetting · 86 points · 2 years ago
Ordered from SSA, got the vial, tested it myself via VendorInvestigate, and it held the claim. Order fulfilled.
2.9k
unpopular opinion: reship is massively overrated
Posting this because I searched for it and got nothing useful. Setup: 0.5mg, week 55, constipation present but not ruining anything. I changed exactly one variable —…
comment on small win: step therapy stopped being a problem at week 35 in c/insurancefights · 6 points · 2 years ago
Did you get step therapy or outright denial?
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
comment on stalled for 6 weeks at 2.4mg and I refuse to panic this time in c/insurancefights · 1 points · 2 years ago
say which country and which plan type
comment on [Discussion] we are measuring Zepbound at the wrong time and calling it noise in c/tirzepatide · 55 points · 2 years ago
Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.
comment on help me understand vendor, I have read the wiki twice in c/vendorvetting · 1 points · 2 years ago
Which service tested it and what did they come back with?
comment on [Lab] SSA tirz — Medutest came back 97.4% against a claimed 96.2% in c/coldchain · 412 points · 2 years ago
no tracking numbers, no full addresses, no label photos — instant removal
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on [Lab] 20th independent test on QSC, and the trend is the interesting part in c/vendorvetting · 44 points · 2 years ago
the Janoshik result being close to the claim is the signal, not the absolute number